Asian Institute of Nephrology and Urology (AINU, Chennai) introduces ‘UroLift’, an advanced treatment for Benign Prostatic Hyperplasia (BPH)

Chennai, July 11, 2023: Asian Institute of Nephrology and Urology (AINU), a leading kidney care specialist in India & Chennai ’s largest nephrology and urology healthcare specialty center, is proud to announce the launch of ‘UroLift’, a leading treatment option for men suffering from Benign Prostatic Hyperplasia (BPH), commonly known as an enlarged prostate. BPH is a prevalent condition among men over the age of 50 and, although non-cancerous, over time it causes the urinary stream to be weak with distressing symptoms, impacting men’s sexual health and overall quality of life. In some cases, it can lead to infection, bladder stones and reduced kidney function. The UroLift is a minimally invasive treatment which does not cause any new, sustained erectile or ejaculatory dysfunction, wherein small implants are placed to lift and hold the enlarged prostate, opening the obstructed urethra that’s blocking the flow of urine.

 
Benign Prostatic Hyperplasia occurs when the prostate gland which surrounds the urethra enlarges, leading to frequent urination during the day and night, slow urine stream, incomplete emptying of the bladder, sudden urgency to urinate, blood in the urine, complete blockage of urine flow and in advanced stages complications such as recurrent urinary tract infections. When medication, the primary approach to treat BPH fails, surgical procedures such as Transurethral Resection of the Prostate (TURP), Holmium Laser Enucleation of the Prostate (HoLEP) or Open/Robotic Prostatectomy are often recommended. While these surgeries carry negligible side effects, they require general anaesthesia or spinal anaesthesia, making them unsuitable for elderly patients or those with underlying health conditions.
 

The UroLift procedure operates by compressing the prostate tissue that obstructs the urethra, resulting in improved urine flow. During the procedure, small permanent MRI compatible implants are strategically placed in the urinary pathway, which is performed under mild sedation or local anaesthesia, ensuring the safety of even elderly patients.
 

Dr. Arun Kumar, Managing Director and Chief Consultant, Asian Institute of Nephrology and Urology (AINU, Chennai) commented, “The UroLift is a onetime procedure which guarantees rapid relief and recovery from BPH symptoms with benefits lasting for a minimum of 5 years as per clinical studies. This procedure will have several aged people benefit from it, as it represents a bladeless and scarless surgical option that can be performed as simple as an outpatient procedure, allowing patients to return home the very same day in most cases. Moreover, post-procedure the recovering patient does not require urinary catheter, which is a huge relief, especially for the elderly men.”
 

Dr. Venkat Subramanium, Executive Director of Asian Institute of Nephrology and Urology (AINU), Chennai said “With an existing comprehensive range of treatment options for BPH, the newly added UroLift treatment will make AINU, a gamechanger in the city’s urology and nephrology space. As the recovery time is minimal and most patients return to their normal routine in a few days’ time, the treatment has proved long-term effectiveness. most importantly in improving the very basic quality of life. Our team of healthcare experts also ensure follow-up visits with the patients to offer post-operative instructions in order to monitor the progress of the treatment.”
 

AINU, Chennai has gained recognition for its exceptional proficiency in the fields of urology and nephrology, delivering state-of-the-art therapies and surgical interventions for a wide range of kidney and urological ailments. The UroLift procedure is yet another milestone achievement added to the existing bouquet of offerings the hospital provides to its patients by its dedicated team of expert doctors.